Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,447
Closed -$1.32M 2025
2025
Q4
$1.32M Buy
19,447
+554
+3% +$40.5K ﹤0.01% 880
2025
Q3
$1.28M Sell
18,893
-520
-3% -$34.5K ﹤0.01% 840
2025
Q2
$1.26M Buy
+19,413
New +$1.16M ﹤0.01% 745
2024
Q1
Sell
-3,903
Closed -$279K 1421
2023
Q4
$279K Buy
3,903
+41
+1% +$2.85K ﹤0.01% 1063
2023
Q3
$268K Buy
3,862
+71
+2% +$5.37K ﹤0.01% 964
2023
Q2
$307K Sell
3,791
-21
-0.6% -$1.72K ﹤0.01% 923
2023
Q1
$308K Buy
3,812
+335
+10% +$27K ﹤0.01% 864
2022
Q4
$260K Buy
+3,477
New +$248K ﹤0.01% 833
2022
Q2
Sell
-2,954
Closed -$226K 995
2022
Q1
$226K Sell
2,954
-1,174
-28% -$84.4K ﹤0.01% 919
2021
Q4
$316K Sell
4,128
-500
-11% -$36.8K ﹤0.01% 782
2021
Q3
$341K Sell
4,628
-555
-11% -$41.6K ﹤0.01% 714
2021
Q2
$346K Buy
5,183
+97
+2% +$6.49K ﹤0.01% 659
2021
Q1
$378K Buy
5,086
+170
+3% +$12.9K 0.01% 581
2020
Q4
$358K Buy
+4,916
New +$347K 0.01% 569

Other funds holding HOLX

Lido Advisors's HOLX Position: Q1 2026 in Review

Lido Advisors sold out of Hologic (HOLX) in Q1 2026, closing a stake of 19,447 shares — an estimated $1.32M sold.

Lido Advisors first reported a position in HOLX in Q4 2020 and held it in 14 quarters. The position peaked at $1.32M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Lido Advisors reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Lido Advisors sold 19,447 Hologic shares in Q1 2026, an estimated $1.32M.
  • Lido Advisors first reported a position in Hologic in Q4 2020 and held it in 14 quarters.
  • Lido Advisors's Hologic position peaked at $1.32M in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.